Industries: Healthtech & Medtech, Biotech & Pharma
Technologies: Robotics, Big Data Other fields: Industry 4.0
Funding stage: Series B (5 M EUR - < 20 M EUR) Founded: 2014 Employees: From 6 to 10
Business model: Others Target: Business
Discovery and development of first-in-class precisión antimicrobial agents for treatment of MDR infections. ABAC shall extensively apply the PasNas Technology Platform to discover novel active compounds to fight infections caused by MDR bacteria.
Institutional buy-out 100%
Investors: Advanded Biotechnologies Investment SL
Minority stake unknown %
Investors: PONTIFAX, GLOBAL HEALTH SCIENCE FUND, CAIXA CAPITAL RISC, DEBIOPHARM INNOVATION FUND Y FERRER
Source: Press releases , newsletters & platforms , company websites , annual reports & accounts , regulatory body sites & stock exchanges
We are continually updating our list of new startups so please let us know if you have recently started one.